Arvee Laboratories (India) Ltd. | Small-cap | Basic Materials
₹167.13
1.90%
| Arvee Laboratories Stock Comparison:
Arvee Laboratories vs Asian PaintsArvee Laboratories vs Pidilite IndustriesArvee Laboratories vs ResponsiveArvee Laboratories vs Balaji AminesArvee Laboratories vs Tanfac IndustriesArvee Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 74.8M
Gross Profit 40.6M 54.29%
Operating Income 488.0K 0.65%
Net Income 1.7M 2.26%
EPS (Diluted) ₹0.15

Balance Sheet Metrics

Total Assets 375.7M
Total Liabilities 63.1M
Shareholders Equity 312.6M
Debt to Equity 0.20

Cash Flow Metrics

Revenue & Profitability Trend

Arvee Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i384.4M303.4M612.8M396.9M471.4M
Cost of Goods Sold i249.3M187.6M439.7M258.8M328.4M
Gross Profit i135.1M115.8M173.1M138.1M143.0M
Gross Margin % i35.1%38.2%28.2%34.8%30.3%
Operating Expenses
Research & Development i---00
Selling, General & Administrative i25.6M22.7M35.3M26.7M25.5M
Other Operating Expenses i50.7K108.4K78.5K510.4K490.3K
Total Operating Expenses i25.7M22.9M35.4M27.2M26.0M
Operating Income i24.6M14.9M52.4M30.0M38.1M
Operating Margin % i6.4%4.9%8.6%7.6%8.1%
Non-Operating Items
Interest Income i4.0M3.6M2.0M2.7M2.8M
Interest Expense i1.5M1.9M2.9M3.1M4.9M
Other Non-Operating Income-----
Pre-tax Income i28.7M18.3M61.7M34.5M36.4M
Income Tax i7.2M7.8M20.5M8.8M9.6M
Effective Tax Rate % i25.2%42.5%33.2%25.4%26.5%
Net Income i21.5M10.5M41.2M25.7M26.8M
Net Margin % i5.6%3.5%6.7%6.5%5.7%
Key Metrics
EBITDA i40.4M34.4M85.6M59.7M64.7M
EPS (Basic) i₹1.95₹0.95₹3.74₹2.34₹3.24
EPS (Diluted) i₹1.95₹0.95₹3.74₹2.34₹3.24
Basic Shares Outstanding i110200001102000011020000110200008524000
Diluted Shares Outstanding i110200001102000011020000110200008524000

Income Statement Trend

Arvee Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i2.1M18.5M5.4M12.8M66.1M
Short-term Investments i47.0M154.3K3.5M18.2M20.3M
Accounts Receivable i84.0M61.1M122.6M121.3M78.8M
Inventory i45.5M64.0M45.7M57.3M74.3M
Other Current Assets-2026.5M-101
Total Current Assets i196.6M167.9M215.7M221.6M255.5M
Non-Current Assets
Property, Plant & Equipment i14.7M14.7M9.1M9.1M9.0M
Goodwill i22.5K22.5K101.5K187.0K272.5K
Intangible Assets i22.5K22.5K101.5K187.0K272.5K
Long-term Investments-----
Other Non-Current Assets-1012.5K25.0K37.5K652.1K
Total Non-Current Assets i179.1M214.1M171.2M165.2M154.9M
Total Assets i375.7M382.0M386.9M386.8M410.5M
Liabilities
Current Liabilities
Accounts Payable i32.7M66.2M79.2M98.4M95.4M
Short-term Debt i00021.3M78.8M
Current Portion of Long-term Debt-----
Other Current Liabilities-10-10-10-10
Total Current Liabilities i38.3M69.4M88.4M132.9M182.9M
Non-Current Liabilities
Long-term Debt i10.3M10.0M10.0M10.0M10.0M
Deferred Tax Liabilities i9.8M8.4M5.0M2.0M3.1M
Other Non-Current Liabilities1010-1.0K-1.0K
Total Non-Current Liabilities i24.9M21.4M17.8M14.5M13.1M
Total Liabilities i63.1M90.8M106.2M147.4M196.1M
Equity
Common Stock i110.2M110.2M110.2M110.2M110.2M
Retained Earnings i183.1M161.6M151.1M109.9M84.8M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i312.6M291.1M280.6M239.4M214.4M
Key Metrics
Total Debt i10.3M10.0M10.0M31.3M88.8M
Working Capital i158.4M98.5M127.3M88.7M72.6M

Balance Sheet Composition

Arvee Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i28.7M18.3M61.7M34.5M36.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i641.9K29.4M-13.6M-50.1M-31.0M
Operating Cash Flow i26.8M46.0M48.9M-15.1M7.5M
Investing Activities
Capital Expenditures i-18.5M-25.9M-14.7M-23.6M-22.4M
Acquisitions i-----
Investment Purchases i-85.0M00--
Investment Sales i86.3M644.8K83.3K21.6M13.6M
Investing Cash Flow i-17.2M-24.6M-14.5M-2.1M-8.9M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i----50.1M
Debt Repayment i---21.3M-57.5M0
Financing Cash Flow i333.0K0-42.6M-115.0M100.2M
Free Cash Flow i-20.6M10.8M14.4M-16.8M-5.8M
Net Change in Cash i10.0M21.5M-8.2M-132.2M98.9M

Cash Flow Trend

Arvee Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 129.96
Price to Book 5.99
Price to Sales 5.06
PEG Ratio -1.58

Profitability Ratios

Profit Margin 3.89%
Operating Margin 0.65%
Return on Equity 6.87%
Return on Assets 5.71%

Financial Health

Current Ratio 5.14
Debt to Equity 3.31
Beta 0.53

Per Share Data

EPS (TTM) ₹1.25
Book Value per Share ₹27.11
Revenue per Share ₹31.98

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
arvee1.9B129.965.996.87%3.89%3.31
Asian Paints 2.3T62.9011.6618.28%10.63%11.42
Pidilite Industries 1.5T69.6415.5420.85%16.16%4.56
Responsive 49.9B24.813.7114.78%13.95%19.05
Balaji Amines 46.1B30.212.497.80%11.11%0.55
Tanfac Industries 45.2B46.4014.3432.50%15.83%13.28

Financial data is updated regularly. All figures are in the company's reporting currency.